Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ACEi, acute, adjunct, Africa, ahead, albumin, angiopathy, angiotensin, antifibrotic, ARB, arterial, ascending, Atlantic, atrophic, atrophy, attack, Australia, autoimmune, autoimmunity, baseline, basement, Bay, begun, bifurcated, bioavailability, blocker, blood, bodily, body, bowel, Brazil, broken, calcineurin, Canadian, carcinoma, cardiac, center, cerebrovascular, Certified, Cherry, China, chloroquine, CKD, claudication, clearance, coagulation, collagen, comparison, compression, concept, concomitant, condensed, confidence, conservative, contemplated, contributor, correlated, coupled, creatinine, Creek, crosslinking, crossover, CSO, curve, daily, deadly, deaggregation, debilitating, debridement, deficiency, deformability, degeneration, Delaplaine, Denver, dermatology, deuterated, deuterium, diarrhea, differentiate, discovery, disgorgement, diversify, driven, dysfunction, earmarked, East, electronically, endothelial, endpoint, enlarge, enzyme, Europe, exacerbation, fat, fed, fine, finite, Firstly, forearm, freestanding, furnish, furnished, gastrointestinal, glycemic, glycoprotein, grafting, granuloma, grown, GSE, handling, Hashimoto, hemorheological, highest, Hood, HWRX, hydrogen, hypothesized, hypoxia, idiopathic, IFN, illegitimate, immune, immunomodulatory, incidence, incurrence, infection, inflammation, inflammatory, inhibitor, injunction, insolvency, installation, Integrium, intermittent, intralesional, intrinsic, IR, IRC, Japan, Japanese, Jose, judged, Korea, Lastly, leasehold, leg, literature, malware, mandated, marker, match, media, medium, membrane, mentioned, merit, Mexico, mg, microcirculatory, migration, missed, misuse, misused, moderate, modification, mouth, multicenter, muscular, nausea, neural, neutrophil, obsolescence, occlusive, omitted, outdated, outweigh, parcel, pathway, pattern, peer, Pennsylvania, pentoxifylline, phishing, phototherapy, physician, Pittsburgh, placebo, platelet, play, pledge, PoC, postulated, Potent, presence, pretibial, proof, psychopathological, PTX, Questor, randomized, range, ransomware, Ratification, receptor, reclassification, red, reform, renal, restructuring, retirement, retroactive, revaluation, revalue, rheumatoid, Russia, SAE, scalp, scarring, scenario, screening, sensitive, serum, skin, social, sophistication, South, Stanker, statistically, step, stream, sublicencee, subscription, suggest, suggested, supervisory, swallowing, Taiwan, taxation, thalidomide, theft, thickening, Thirdly, Thornton, thrice, ticker, TNF, toxicity, toxicological, toxicology, transmission, trauma, Trental, trunk, Tustin, UACR, unclear, unlimited, unregistered, untitled, upcoming, UPMC, urinary, UV, vascular, Virgil, volunteer, vomiting, Wendy, whichever, worth, wound, yellow
Removed:
accurately, arrive, assume, billed, calculation, carefully, closed, Colorado, comparing, consisting, context, Dakota, denominator, detail, detection, discontinued, discount, discounted, expressed, factor, fifty, filer, Hardy, hereof, Independence, insignificant, interpret, lacking, leased, line, loan, maximize, North, numerator, offered, offering, opt, organized, Pave, pertain, preventative, prevention, Pritchett, processed, promissory, promulgated, read, replacement, reportable, revolving, satisfied, separated, settle, Siler, sum, summarized, surviving, suspended, traffic, Undistributed, unsecured, Utah
Filing tables
Filing exhibits
PCSA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement Number 333-190697 on Form S-8 of our report, dated March 28, 2019, relating to the consolidated financial statements of Processa Pharmaceuticals, Inc. in the Annual report on Form 10-K of Processa Pharmaceuticals, Inc. for the years ended December 31, 2018 and 2017.
/s/ BD & Company, Inc. | |
Owings Mills, MD | |
March 28, 2019 |